(Updated - July 24, 2024 6:54 AM EDT)

Leerink Partners analyst Mani Foroohar upgraded Ionis Pharmaceuticals (NASDAQ: IONS) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE